gabexate has been researched along with Ureteral Obstruction in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morinaga, J | 1 |
| Kakizoe, Y | 1 |
| Miyoshi, T | 1 |
| Onoue, T | 1 |
| Ueda, M | 1 |
| Mizumoto, T | 1 |
| Yamazoe, R | 1 |
| Uchimura, K | 1 |
| Hayata, M | 1 |
| Shiraishi, N | 1 |
| Adachi, M | 1 |
| Sakai, Y | 1 |
| Tomita, K | 1 |
| Kitamura, K | 1 |
1 other study available for gabexate and Ureteral Obstruction
| Article | Year |
|---|---|
The antifibrotic effect of a serine protease inhibitor in the kidney.
Topics: Animals; Cell Line; Chemokine CCL2; Esters; Fibroblasts; Gabexate; Guanidines; Macrophages; Nephrosc | 2013 |